The impact of minor histocompatibility antigens in allogeneic stem cell transplantation - Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation - page 53

[27] Loveland B, Wang CR, Yonekawa H, Hermel E, Lindahl KF. Maternally transmitted
histocompatibility antigen of mice: a hydrophobic peptide of a mitochondrially en-
coded protein. Cell 1990;60:971-80.
[28] Falk K, Rotzschke O, Rammensee HG. Cellular peptide composition governed by major
histocompatibility complex class I molecules. Nature 1990;348:248-51.
[29] Rotzschke O, Falk K, Wallny HJ, Faath S, Rammensee HG. Characterization of naturally
occurring minor histocompatibility peptides including H-4 and H-Y. Science 1990;249:283-7.
[30] Wang W, Meadows LR, den Haan JM, Sherman NE, Chen Y, Blokland E, et al. Human
H-Y: a male-specific histocompatibility antigen derived from the SMCY protein.
Science 1995;269:1588-90.
[31] den Haan JM, Sherman NE, Blokland E, Huczko E, Koning F, Drijfhout JW, et al.
Identification of a graft versus host disease-associated human minor histocompatibility
antigen. Science 1995;268:1476-80.
[32] den Haan JM, Meadows LM, Wang W, Pool J, Blokland E, Bishop TL, et al. The minor
histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymor-
phism. Science 1998;279:1054-7.
[33] Vogt MH, Goulmy E, Kloosterboer FM, Blokland E, de Paus RA, Willemze R, et al. UTY
gene codes for an HLA-B60-restricted human male-specific minor histocompatibility
antigen involved in stem cell graft rejection: characterization of the critical polymor-
phic amino acid residues for T-cell recognition. Blood 2000;96:3126-32.
[34] Warren III EH, Gavin MA, Simpson E, Chandler P, Page DC, Disteche C, et al. The
human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. J Immunol
2000;164:2807-14.
[35] Dolstra H, de Rijke B, Fredrix H, Balas A, Maas F, Scherpen F, et al. van de Wiel-van
Kemenade. Bi-directional allelic recognition of the human minor histocompatibility
antigen HB-1 by cytotoxic T lymphocytes. Eur J Immunol 2002;32:2748-58.
[36] Mommaas B, Kamp J, Drijfhout JW, Beekman NJ, Ossendorp F, van Veelen PA, et al.
Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompat-
ibility antigen HA-1 locus. J Immunol 2002;169:3131-6.
[37] Vogt MH, van den Muijsenberg JW, Goulmy E, Spierings E, Kluck P, Kester MG, et al.
The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocom-
patibility antigen involved in graft-versus-host disease. Blood 2002;99:3027-32.
[38] Murata M, Warren III EH, Riddell SR. A human minor histocompatibility antigen result-
ing from differential expression due to a gene deletion. J Exp Med 2003;197:1279-89.
[39] Akatsuka Y, Nishida T, Kondo E, Miyazaki M, Taji H, Iida H, et al. Identification of a
polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor
histocompatibility antigens. J Exp Med 2003;197:1489-500.
[40] Spierings E, Brickner AG, Caldwell JA, Zegveld S, Tatsis N, Blokland E, et al. The minor
histocompatibility antigen HA-3 arises from differential proteasome-mediated cleav-
age of the lymphoid blast crisis (Lbc) oncoprotein. Blood 2003;102:621-9.
[41] Spierings E, Vermeulen CJ, Vogt MH, Doerner LE, Falkenburg JH, Mutis T, et al. Identi-
fication of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4 + T-helper
cells in H-Y-mismatched transplantation. Lancet 2003;362:610-5.
[42] Torikai H, Akatsuka Y, Miyazaki M, Warren III EH, Oba T, Tsujimura K, et al. A novel
HLA-A*3303-restricted minor histocompatibility antigen encoded by an unconven-
tional open reading frame of human TMSB4Y gene. J Immunol 2004;173:7046-54.
[43] de Rijke B, van Horssen-Zoetbrood A, Beekman JM, Otterud BE, Maas F, Woestenenk
R, et al. A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lympho-
cyte response associated with remission of chronic myeloid leukemia. J Clin Invest
2005;115:3506-16.
[44] Brickner AG, Evans AM, Mito JK, Xuereb SM, Feng X, Nishida T, et al. The PANE1 gene
encodes a novel human minor histocompatibility antigen that is selectively expressed
in B-lymphoid cells and B-CLL. Blood 2006;107:3779-86.
[45] Warren III EH, Vigneron NJ, Gavin MA, Coulie PG, Stroobant V, Dalet A, et al. An
antigen produced by splicing of noncontiguous peptides in the reverse order. Science
2006;313:1444-7.
[46] Spaapen RM, Lokhorst HM, van den OK, Otterud BE, Dolstra H, Leppert MF, et al.
Toward targeting B cell cancers with CD4 + CTLs: identification of a CD19-encoded
minor histocompatibility antigen using a novel genome-wide analysis. J Exp Med
2008;205:2863-72.
[47] Tykodi SS, Fujii N, Vigneron NJ, Lu SM, Mito JK, Miranda MX, et al. C19orf48 encodes a
minor histocompatibility antigen recognized by CD8 + cytotoxic T cells from renal cell
carcinoma patients. Clin Cancer Res 2008;14:5260-9.
[48] Kawase T, Nannya Y, Torikai H, Yamamoto G, Onizuka M, Morishima S, et al. Identifica-
tion of human minor histocompatibility antigens based on genetic association with
highly parallel genotyping of pooled DNA. Blood 2008;111:3286-94.

54